REMEDY Stock Overview
A video game company, engages in the development and sale of games for PC and console platforms in Finland.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for REMEDY from our risk checks.
Remedy Entertainment Oyj Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €17.12 |
52 Week High | €30.65 |
52 Week Low | €15.66 |
Beta | 0.52 |
11 Month Change | -1.61% |
3 Month Change | -8.55% |
1 Year Change | -29.26% |
33 Year Change | -58.65% |
5 Year Change | 75.05% |
Change since IPO | 155.90% |
Recent News & Updates
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For Remedy Entertainment Oyj (HEL:REMEDY)
Jun 14Analyst Forecasts Just Got A Lot More Bearish On Remedy Entertainment Oyj (HEL:REMEDY)
Feb 20Health Check: How Prudently Does Remedy Entertainment Oyj (HEL:REMEDY) Use Debt?
Oct 27Calculating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Sep 15Does Remedy Entertainment Oyj (HEL:REMEDY) Have A Healthy Balance Sheet?
Apr 05Remedy Entertainment Oyj (HEL:REMEDY) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 15The Returns On Capital At Remedy Entertainment Oyj (HEL:REMEDY) Don't Inspire Confidence
Apr 29Remedy Entertainment Oyj (HEL:REMEDY) Has A Pretty Healthy Balance Sheet
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Shares Could Be 35% Below Their Intrinsic Value Estimate
Feb 16Investors Could Be Concerned With Remedy Entertainment Oyj's (HEL:REMEDY) Returns On Capital
Dec 30Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?
May 22Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
May 04Investors Who Bought Remedy Entertainment Oyj (HEL:REMEDY) Shares Three Years Ago Are Now Up 557%
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Seems To Use Debt Rather Sparingly
Feb 16Should You Rely On Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Growth?
Feb 04Calculating The Fair Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Jan 19Under The Bonnet, Remedy Entertainment Oyj's (HEL:REMEDY) Returns Look Impressive
Jan 05Is Now The Time To Put Remedy Entertainment Oyj (HEL:REMEDY) On Your Watchlist?
Dec 21Did You Miss Remedy Entertainment Oyj's (HEL:REMEDY) Whopping 388% Share Price Gain?
Dec 06Remedy Entertainment Oyj (HEL:REMEDY) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 20Shareholder Returns
REMEDY | FI Entertainment | FI Market | |
---|---|---|---|
7D | -1.5% | -13.1% | 0.6% |
1Y | -29.3% | -9.1% | -7.9% |
Return vs Industry: REMEDY underperformed the Finnish Entertainment industry which returned -10.9% over the past year.
Return vs Market: REMEDY underperformed the Finnish Market which returned -8.8% over the past year.
Price Volatility
REMEDY volatility | |
---|---|
REMEDY Average Weekly Movement | 4.7% |
Entertainment Industry Average Movement | 5.9% |
Market Average Movement | 4.3% |
10% most volatile stocks in FI Market | 8.8% |
10% least volatile stocks in FI Market | 2.6% |
Stable Share Price: REMEDY has not had significant price volatility in the past 3 months.
Volatility Over Time: REMEDY's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 352 | Tero Virtala | www.remedygames.com |
Remedy Entertainment Oyj, a video game company, engages in the development and sale of games for PC and console platforms in Finland. It primarily creates story-driven and visually stunning action games. The company also provides franchises under the Alan Wake, Control, and Max Payne brand names.
Remedy Entertainment Oyj Fundamentals Summary
REMEDY fundamental statistics | |
---|---|
Market cap | €232.30m |
Earnings (TTM) | -€22.66m |
Revenue (TTM) | €33.93m |
6.8x
P/S Ratio-10.3x
P/E RatioIs REMEDY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
REMEDY income statement (TTM) | |
---|---|
Revenue | €33.93m |
Cost of Revenue | €16.84m |
Gross Profit | €17.09m |
Other Expenses | €39.75m |
Earnings | -€22.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 09, 2024
Earnings per share (EPS) | -1.67 |
Gross Margin | 50.37% |
Net Profit Margin | -66.77% |
Debt/Equity Ratio | 1.4% |
How did REMEDY perform over the long term?
See historical performance and comparison